Login
ASTRAZENECA PLC logo

ASTRAZENECA PLC

astrazeneca.com

What Do They Do?

Sells prescription medicines for cancer, rare diseases and other conditions to government payers, managed-care organizations and hospitals.

How Do They Make Money?

AstraZeneca sells medicines, with payment tied to when products ship or arrive. It also earns shares or royalties from partner sales and receives upfront or milestone payments for licensed product rights.

FY2025 revenue

Who Are Their Customers?

Customers include government payers and managed-care organizations, healthcare institutions such as hospitals and long-term care facilities, and group purchasing organizations; some partner arrangements involve sales made by collaboration partners.

Do Revenues Turn Into Profits?

Yes. It kept 17 cents of every revenue dollar as net income in FY2025 and turned 20 cents into free cash flow.

Operating income, FY2025
23% of revenue
▲ +37% vs FY2024 ($10B, 18%)
Net income, FY2025
17% of revenue
▲ +45% vs FY2024 ($7B, 13%)
Free cash flow, FY2025
20% of revenue
▲ +18% vs FY2024 ($9.9B, 18%)

How Are They Changing?

Growing. Revenue grew 57% in 4 years, from $37.4B in FY2021 to $58.7B in FY2025, about 12% a year.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support